8 results on '"Ndaro, Arnold"'
Search Results
2. Toxoplasma gondii seroprevalence among pregnant women attending antenatal clinic in Northern Tanzania
- Author
-
Paul, Eliakimu, Kiwelu, Ireen, Mmbaga, Blandina, Nazareth, Rebeka, Sabuni, Elias, Maro, Athanasia, Ndaro, Arnold, Halliday, Jo E. B., and Chilongola, Jaffu
- Published
- 2018
- Full Text
- View/download PDF
3. Africa’s oesophageal cancer corridor: Do hot beverages contribute?
- Author
-
Munishi, Michael Oresto, Hanisch, Rachel, Mapunda, Oscar, Ndyetabura, Theonest, Ndaro, Arnold, Schüz, Joachim, Kibiki, Gibson, and McCormack, Valerie
- Published
- 2015
- Full Text
- View/download PDF
4. Prevalence of dengue and chikungunya virus infections in north-eastern Tanzania: a cross sectional study among participants presenting with malaria-like symptoms.
- Author
-
Kajeguka, Debora C., Kaaya, Robert D., Mwakalinga, Steven, Ndossi, Rogathe, Ndaro, Arnold, Chilongola, Jaffu O., Mosha, Franklin W., Schiøler, Karin L., Kavishe, Reginald A., and Alifrangis, Michael
- Subjects
DENGUE ,CHIKUNGUNYA virus ,DISEASE prevalence ,CROSS-sectional method ,ALPHAVIRUS diseases ,RNA metabolism ,RNA analysis ,COMPARATIVE studies ,ENZYME-linked immunosorbent assay ,EXANTHEMA ,FLAVIVIRUSES ,HEADACHE ,IMMUNOGLOBULINS ,RESEARCH methodology ,MEDICAL cooperation ,POLYMERASE chain reaction ,RESEARCH ,VIRAL antibodies ,EVALUATION research ,CHIKUNGUNYA ,JOINT pain - Abstract
Background: In spite of increasing reports of dengue and chikungunya activity in Tanzania, limited research has been done to document the general epidemiology of dengue and chikungunya in the country. This study aimed at determining the sero-prevalence and prevalence of acute infections of dengue and chikungunya virus among participants presenting with malaria-like symptoms (fever, headache, rash, vomit, and joint pain) in three communities with distinct ecologies of north-eastern Tanzania.Methods: Cross sectional studies were conducted among 1100 participants (aged 2-70 years) presenting with malaria-like symptoms at health facilities at Bondo dispensary (Bondo, Tanga), Hai hospital (Hai, Kilimanjaro) and TPC hospital (Lower Moshi). Participants who were malaria negative using rapid diagnostic tests (mRDT) were screened for sero-positivity towards dengue and chikungunya Immunoglobulin G and M (IgG and IgM) using ELISA-based kits. Participants with specific symptoms defined as probable dengue and/or chikungunya by WHO (fever and various combinations of symptoms such as headache, rash, nausea/vomit, and joint pain) were further screened for acute dengue and chikungunya infections by PCR.Results: Out of a total of 1100 participants recruited, 91.2 % (n = 1003) were malaria negative by mRDT. Out of these, few of the participants (<5 %) were dengue IgM or IgG positive. A total of 381 participants had fever out of which 8.7 % (33/381) met the defined criteria for probable dengue, though none (0 %) was confirmed to be acute cases. Chikungunya IgM positives among febrile participants were 12.9 % (49/381) while IgG positives were at 3.7 % (14/381). A total of 74.2 % (283/381) participants met the defined criteria for probable chikungunya and 4.2 % (11/263) were confirmed by PCR to be acute chikungunya cases. Further analyses revealed that headache and joint pain were significantly associated with chikungunya IgM seropositivity.Conclusion: In north-eastern Tanzania, mainly chikungunya virus appears to be actively circulating in the population. Continuous surveillance is needed to determine the contribution of viral infections of fever cases. A possible establishment of arboviral vector preventive control measures and better diagnosis of pathogens to avoid over-treatment of other diseases should be considered. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
5. Trends in chloroquine resistance marker, Pfcrt- K76T mutation ten years after chloroquine withdrawal in Tanzania.
- Author
-
Mohammed, Asia, Ndaro, Arnold, Kalinga, Akili, Manjurano, Alphaxard, Mosha, Jackline F., Mosha, Dominick F., van Zwetselaar, Marco, Koenderink, Jan B., Mosha, Frank W., Alifrangis, Michael, Reyburn, Hugh, Roper, Cally, and Kavishe, Reginald A.
- Subjects
- *
CHLOROQUINE , *ANTIMALARIALS , *MALARIA prevention , *PLASMODIUM falciparum , *INFECTIOUS disease transmission - Abstract
Background Plasmodium falciparum resistance to anti-malarial drugs remains a major obstacle to the control of malaria. In 2001 Tanzania replaced chloroquine (CQ) with sulphadoxinepyrimethamine (SP) as first-line drug, which in turn was replaced by artemisinin combination therapy in 2006. SP has however, continued to be used in intermittent preventive treatment of malaria in pregnancy (IPTp) despite reports of high levels of resistance to SP due to the lack of alternatives to SP for IPTp. Recent reports have indicated recovery of CQ-susceptibility in Malawi, Kenya, Mozambique, and Tanzania based on the prevalence of wild types at codon 76 of the Pfcrt gene in indigenous P. falciparum populations. The current prevalence of this Pfcrt-76 CQ resistance marker from six regions of Tanzania mainland is hereby reported. Methods DNA extracted from filter-paper dried blood spots and rapid diagnostics kit strips collected from finger-prick blood were used to genotype the Pfcrt-76 resistance marker using PCRRFLP. Data from previously published studies were used to generate CQ susceptibility recovery trends using logistic regression model. Results Seven hundred and forty one (741) samples were genotyped. The current frequency of the CQ-susceptible Pfcrt-K76 was above 92% and did not differ between regions in Tanzania (χ2 = 2.37; p = 0.795). The K76 allelic prevalence was between 85.7 and 93% in regions (χ2 = 7.88, p = 0.163). The CQ resistance recovery trends showed regional variability that may be caused by differences in malaria transmission intensity, but overall the trends converge as the susceptibility levels in all regions approach >90%. Conclusions CQ withdrawal in Tanzania has resulted into >90% recovery of susceptibility in ten years of withdrawal. These findings are in support of the search for CQ-based combination drugs as a possible future alternative to SP for IPTp in places where full recovery of CQ-susceptibility will be evident. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
6. Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay.
- Author
-
Rugemalila, Joan, Maro, Venance P., Kapanda, Gibson, Ndaro, Arnold J., and Jarvis, Joseph N.
- Subjects
CRYPTOCOCCALES ,HIV-positive persons ,TANZANIANS ,CROSS-sectional method ,ANTIRETROVIRAL agents ,ANTIFUNGAL agents ,CD4 antigen - Abstract
Copyright of Tropical Medicine & International Health is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2013
- Full Text
- View/download PDF
7. Defining malaria burden from morbidity and mortality records, self treatment practices and serological data in Magugu, Babati District, northern Tanzania.
- Author
-
MWANZIVA, CHARLES, MANJURANO, ALPHAXARD, MBUGI, ERASTO, MWEYA, CLEMENT, MKALI, HUMPHREY, KIVUYO, MAGGIE P., SANGA, ALEX, NDARO, ARNOLD, CHAMBO, WILLIAM, MKWIZU, ABAS, KITAU, JOVIN, KAVISHE, REGINALD, DOLMANS, WIL, CHILONGOLA, JAFFU, and MOSHA, FRANKLIN W.
- Abstract
Malaria morbidity and mortality data from clinical records provide essential information towards defining disease burden in the area and for planning control strategies, but should be augmented with data on transmission intensity and serological data as measures for exposure to malaria. The objective of this study was to estimate the malaria burden based on serological data and prevalence of malaria, and compare it with existing self-treatment practices in Magugu in Babati District of northern Tanzania. Prospectively, 470 individuals were selected for the study. Both microscopy and Rapid Diagnostic Test (RDT) were used for malaria diagnosis. Seroprevalence of antibodies to merozoite surface proteins (MSP- 119) and apical membrane antigen (AMA-1) was performed and the entomological inoculation rate (EIR) was estimated. To complement this information, retrospective data on treatment history, prescriptions by physicians and use of bed nets were collected. Malaria prevalence in the area was 6.8% (32/470). Of 130 individuals treated with artemisinin combination therapy (ACT), 22.3 % (29/130) were slide confirmed while 75.3% (98/130) of them were blood smear negative. Three of the slides confirmed individuals were not treated with ACT. Fever was reported in 38.2% of individuals, of whom 48.8 % (88/180) were given ACT. Forty-two (32.3%) of those who received ACT had no history of fever. About half (51.1%) of those treated with ACT were children <10 years old. Immunoglobulin against MSP-119 was positive in 16.9% (74/437) while against AMA-1 was positive in 29.8 % (130/436). Transmission intensity was estimated at <0.2 infectious bites per person per year. The RDT was highly specific (96.3%) but with low sensitivity (15.6%). In conclusion, Magugu is a low endemic area. There is substantial over diagnosis, over treatment and self treatment in the community. The burden of malaria based on medical records is over estimated as was mostly presumptive. The low sensitivity of RDT reflects the low number of immune individuals as well as the low parasite density. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
8. Herpes Simplex virus type 2 seroprevalence and risk factors among adolescents and youth with HIV-1 in Northern, Tanzania.
- Author
-
Madebe, Rashid, Kiwelu, Ireen, Ndaro, Arnold, Francis, Filbert, Baraka, Vito, Theilgaard, Zahra, and Katzenstein, Terese
- Subjects
- *
HERPES simplex virus , *HIV , *SEROPREVALENCE , *TEENAGERS , *SEXUAL intercourse , *ERYTHEMA multiforme - Abstract
Introduction: Herpes Simplex virus type 2 (HSV-2) infection is associated with an increased risk of human immunodeficiency virus type 1 (HIV-1) acquisition and transmission. Individuals co-infected with HIV-1 and HSV-2 may have longer lasting, more frequent and severe outbreaks of herpes symptoms. Previous studies have assessed HSV-2 seroprevalence and associated risk factors in adult populations. However, there is limited data on the HSV-2 seroprevalence among adolescents and youth living with HIV-1. The study aimed to determine the HSV-2 seroprevalence and associated risk factors among adolescents and youth living with HIV-1 at referral hospital setting in Northern Tanzania. Methodology: A cross-sectional survey was conducted between February and July 2017 among HIV-1-infected individuals aged 10-24 years attending the Child -Centred Family Care Clinic at Kilimanjaro Christian Medical Centre. Blood specimens from 180 individuals were collected for ELISA-based detection of HSV-2 antibodies. Associations between risk factors and HSV-2 seroprevalence were analysed by univariate and multivariate logistic regression models. Results: The overall HSV-2 seroprevalence was 18% (32/180). A significant HSV-2 seroprevalence was noted among adolescents and youth, who reported having had sexual intercourse than those who never had sexual intercourse (28.9% vs 13.3%, p = 0.02). Youths aged 20-24 had six folds higher risk of HSV-2 seroprevalence compared to those aged 10-14 years (AOR = 5.97 95% CI 1.31 - 27.19, p = 0.02). Conclusions: Our study found that HSV-2 seroprevalence increased by age among adolescents and youth living with HIV-1. Age-specific approaches might play an important role in interventions targeting HSV-2 infection. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.